Clinical trials with recombinant allergens--three perspectives: industry.
Narkus
Annemie
A
Allergopharma Joachim Ganzer KG, Reinbek.
Kniest
Frans
F
Menzel
Anja
A
Meyer
Hanns
H
Sprung
Viola
V
D000485:Allergens / Q000008:administration & dosage / Q000627:therapeutic use*; D052179:Antigens, Plant / Q000008:administration & dosage / Q000627:therapeutic use; D029662:Betula / Q000009:adverse effects / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods*; D004345:Drug Industry; D006801:Humans; D010940:Plant Proteins / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D011058:Pollen / Q000276:immunology; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy
D000485:Allergens; D052179:Antigens, Plant; D010940:Plant Proteins; D011994:Recombinant Proteins